ArticleClinical rheumatology2026
Anti-CD74 IgA is not associated with modic changes in the Northern Finland Birth Cohort.
Article in Clinical rheumatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
objectivesChronic low back pain is a common symptom in axial spondyloarthritis (axSpA) and in patients with degenerative spinal disease associated with Modic changes (MC) on MRI. A clear distinction between axSpA and MC might be difficult in early disease, particularly in the absence of axSpA sacroiliac changes. Therefore, a diagnostic serum biomarker for ambiguous cases would be useful. To evaluate if the potential diagnostic biomarker anti-CD74 for axSpA is elevated in patients with MC as well, we measured this antibody in patients with MC and healthy controls. We presumed that a negative anti-CD74 antibody in MC would be helpful to distinguish it from axSpA.
methodParticipants from the NFBC1966 with MC and matched participants without MC were included in this study. Anti-CD74 immunoglobulin A (IgA) was measured with a commercially available kit. An association between continuous log-transformed anti-CD74 IgA was evaluated with a linear regression model adjusted for body mass index (BMI), sex, C-reactive protein (CRP), and presence of low back pain.
resultsThe study involved 307 participants, 148 with MC and 159 without MC. There was no association between MC and continuous anti-CD74 IgA after adjustment for potential confounders (Exp(B) = 1.3, 95% CI 0.8 to 2.1). None of the participants with MC had elevated anti-CD74 IgA above the cut-off of 15 U/ml.
conclusionsAnti-CD74 IgA is not elevated in patients with MC. Further studies comparing directly patients with axSpA and MC are required to evaluate if it is a diagnostic tool to differentiate axSpA and MC in unclear cases. Key Points • Anti-CD74 IgA are not elevated in patients with Modic changes on MRI.
Indexed as
Identifiers
41670939What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.